A new proof-of-concept study led by researchers from the University of Oxford in the United Kingdom suggests that a new drug, called “etokimab,” could be an effective alternative for atopic dermatitis. Their findings appear in the journal Science Translational Medicine, and the researchers thank AnaptysBio, a clinical-stage antibody development company, for funding the small trial. Atopic Dermatitis […]